BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu VC, Huang KH, Peng KY, Tsai YC, Wu CH, Wang SM, Yang SY, Lin LY, Chang CC, Lin YH, Lin SL, Chu TS, Wu KD. Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population. Sci Rep 2015;5:11396. [PMID: 26066391 DOI: 10.1038/srep11396] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Wu VC, Hu YH, Er LK, Yen RF, Chang CH, Chang YL, Lu CC, Chang CC, Lin JH, Lin YH, Wang TD, Wang CY, Tu ST, Jeff Chueh SC, Chang CC, Tseng FY, Wu KD; TAIPAI group. Case detection and diagnosis of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism. J Formos Med Assoc 2017;116:993-1005. [PMID: 28735660 DOI: 10.1016/j.jfma.2017.06.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
2 Chen Y, Peng K, Chueh JS, Liao H, Hsieh T, Wu V, Wang S. Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology. Front Endocrinol 2022;13:816754. [DOI: 10.3389/fendo.2022.816754] [Reference Citation Analysis]
3 Omata K, Tomlins SA, Rainey WE. Aldosterone-Producing Cell Clusters in Normal and Pathological States. Horm Metab Res 2017;49:951-6. [PMID: 29202494 DOI: 10.1055/s-0043-122394] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
4 Tauber P, Aichinger B, Christ C, Stindl J, Rhayem Y, Beuschlein F, Warth R, Bandulik S. Cellular Pathophysiology of an Adrenal Adenoma-Associated Mutant of the Plasma Membrane Ca(2+)-ATPase ATP2B3. Endocrinology 2016;157:2489-99. [PMID: 27035656 DOI: 10.1210/en.2015-2029] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
5 Remde H, Dietz A, Emeny R, Riester A, Peters A, de las Heras Gala T, Then C, Seissler J, Beuschlein F, Reincke M, Quinkler M. The cardiovascular markers copeptin and high-sensitive C-reactive protein decrease following specific therapy for primary aldosteronism. Journal of Hypertension 2016;34:2066-73. [DOI: 10.1097/hjh.0000000000001041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Hong AR, Kim JH, Song YS, Lee KE, Seo SH, Seong MW, Shin CS, Kim SW, Kim SY. Genetics of Aldosterone-Producing Adenoma in Korean Patients. PLoS One 2016;11:e0147590. [PMID: 26807823 DOI: 10.1371/journal.pone.0147590] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
7 Omata K, Satoh F, Morimoto R, Ito S, Yamazaki Y, Nakamura Y, Anand SK, Guo Z, Stowasser M, Sasano H, Tomlins SA, Rainey WE. Cellular and Genetic Causes of Idiopathic Hyperaldosteronism. Hypertension 2018;72:874-80. [PMID: 30354720 DOI: 10.1161/HYPERTENSIONAHA.118.11086] [Cited by in Crossref: 65] [Cited by in F6Publishing: 40] [Article Influence: 21.7] [Reference Citation Analysis]
8 Boulkroun S, Fernandes-Rosa FL, Zennaro MC. Old and new genes in primary aldosteronism. Best Pract Res Clin Endocrinol Metab 2020;34:101375. [PMID: 32007424 DOI: 10.1016/j.beem.2020.101375] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Scholl UI, Abriola L, Zhang C, Reimer EN, Plummer M, Kazmierczak BI, Zhang J, Hoyer D, Merkel JS, Wang W, Lifton RP. Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma. J Clin Invest 2017;127:2739-50. [PMID: 28604387 DOI: 10.1172/JCI91733] [Cited by in Crossref: 41] [Cited by in F6Publishing: 14] [Article Influence: 8.2] [Reference Citation Analysis]
10 Lu CC, Yen RF, Peng KY, Huang JY, Wu KD, Chueh JS, Lin WY. NP-59 Adrenal Scintigraphy as an Imaging Biomarker to Predict KCNJ5 Mutation in Primary Aldosteronism Patients. Front Endocrinol (Lausanne) 2021;12:644927. [PMID: 33995277 DOI: 10.3389/fendo.2021.644927] [Reference Citation Analysis]
11 Peng KY, Liao HW, Chueh JS, Pan CY, Lin YH, Chen YM, Chen PY, Huang CL, Wu VC. Pathophysiological and Pharmacological Characteristics of KCNJ5 157-159delITE Somatic Mutation in Aldosterone-Producing Adenomas. Biomedicines 2021;9:1026. [PMID: 34440230 DOI: 10.3390/biomedicines9081026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Azizan EA, Brown MJ. Novel genetic determinants of adrenal aldosterone regulation. Curr Opin Endocrinol Diabetes Obes 2016;23:209-17. [PMID: 26992195 DOI: 10.1097/MED.0000000000000255] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
13 Lee B, Kang VJ, Pan C, Huang J, Lin Y, Chang Y, Tsai C, Chou C, Chen Z, Liao C, Chiu Y, Wu V, Hung C, Chang C, Lin Y. KCNJ5 Somatic Mutation Is Associated With Higher Aortic Wall Thickness and Less Calcification in Patients With Aldosterone-Producing Adenoma. Front Endocrinol 2022;13:830130. [DOI: 10.3389/fendo.2022.830130] [Reference Citation Analysis]
14 Benham JL, Eldoma M, Khokhar B, Roberts DJ, Rabi DM, Kline GA. Proportion of Patients With Hypertension Resolution Following Adrenalectomy for Primary Aldosteronism: A Systematic Review and Meta-Analysis. J Clin Hypertens 2016;18:1205-12. [DOI: 10.1111/jch.12916] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
15 Zennaro MC, Boulkroun S, Fernandes-Rosa F. Genetic Causes of Functional Adrenocortical Adenomas. Endocr Rev 2017;38:516-37. [PMID: 28973103 DOI: 10.1210/er.2017-00189] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 11.0] [Reference Citation Analysis]
16 Stindl J, Tauber P, Sterner C, Tegtmeier I, Warth R, Bandulik S. Pathogenesis of Adrenal Aldosterone-Producing Adenomas Carrying Mutations of the Na(+)/K(+)-ATPase. Endocrinology 2015;156:4582-91. [PMID: 26418325 DOI: 10.1210/en.2015-1466] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
17 El Zein RM, Boulkroun S, Fernandes-Rosa FL, Zennaro MC. Molecular genetics of Conn adenomas in the era of exome analysis. Presse Med 2018;47:e151-8. [PMID: 30072045 DOI: 10.1016/j.lpm.2018.07.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
18 Chang CH, Hu YH, Huang KH, Lin YH, Tsai YC, Wu CH, Yang SY, Chang CC, Lu CC, Wu KD, Wu VC. Higher Screening Aldosterone to Renin Ratio in Primary Aldosteronism Patients with Diabetes Mellitus. J Clin Med 2018;7:E360. [PMID: 30332741 DOI: 10.3390/jcm7100360] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
19 Wang JJ, Peng KY, Wu VC, Tseng FY, Wu KD. CTNNB1 Mutation in Aldosterone Producing Adenoma. Endocrinol Metab (Seoul) 2017;32:332-8. [PMID: 28956362 DOI: 10.3803/EnM.2017.32.3.332] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
20 Wu VC, Wang SM, Chueh SJ, Yang SY, Huang KH, Lin YH, Wang JJ, Connolly R, Hu YH, Gomez-Sanchez CE, Peng KY, Wu KD. The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes. Sci Rep 2017;7:39121. [PMID: 28102204 DOI: 10.1038/srep39121] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 7.6] [Reference Citation Analysis]
21 Mohideen SK, Mustangin M, Kamaruddin NA, Muhammad R, Jamal ARA, Sukor N, Tan GC, Azizan EA. Prevalence and Histopathological Characteristics of KCNJ5 Mutant Aldosterone-Producing Adenomas in a Multi-Ethnic Malaysian Cohort. Front Endocrinol (Lausanne) 2019;10:666. [PMID: 31636604 DOI: 10.3389/fendo.2019.00666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Nanba K, Rainey WE, Udager AM. Approaches to Gene Mutation Analysis Using Formalin-Fixed Paraffin-Embedded Adrenal Tumor Tissue From Patients With Primary Aldosteronism. Front Endocrinol (Lausanne) 2021;12:683588. [PMID: 34267727 DOI: 10.3389/fendo.2021.683588] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Stowasser M, Gordon RD. Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney. Physiological Reviews 2016;96:1327-84. [DOI: 10.1152/physrev.00026.2015] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 11.2] [Reference Citation Analysis]
24 Chen YY, Lin YH, Huang WC, Chueh E, Chen L, Yang SY, Lin PC, Lin LY, Lin YH, Wu VC, Chu TS, Wu KD. Adrenalectomy Improves the Long-Term Risk of End-Stage Renal Disease and Mortality of Primary Aldosteronism. J Endocr Soc 2019;3:1110-26. [PMID: 31086833 DOI: 10.1210/js.2019-00019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
25 Fernandes-Rosa FL, Boulkroun S, Zennaro MC. Somatic and inherited mutations in primary aldosteronism. J Mol Endocrinol 2017;59:R47-63. [PMID: 28400483 DOI: 10.1530/JME-17-0035] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 5.4] [Reference Citation Analysis]
26 Itcho K, Oki K, Ohno H, Yoneda M. Update on Genetics of Primary Aldosteronism. Biomedicines 2021;9:409. [PMID: 33920271 DOI: 10.3390/biomedicines9040409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 Mourtzi N, Sertedaki A, Markou A, Piaditis GP, Charmandari E. Unravelling the Genetic Basis of Primary Aldosteronism. Nutrients 2021;13:875. [PMID: 33800142 DOI: 10.3390/nu13030875] [Reference Citation Analysis]
28 Meyer DJ, Gatto C, Artigas P. On the effect of hyperaldosteronism-inducing mutations in Na/K pumps. J Gen Physiol 2017;149:1009-28. [PMID: 29030398 DOI: 10.1085/jgp.201711827] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
29 Peng K, Chang H, Lin Y, Chan C, Chang C, Chueh SJ, Yang S, Huang K, Lin Y, Wu V, Wu K. miRNA-203 Modulates Aldosterone Levels and Cell Proliferation by Targeting Wnt5a in Aldosterone-Producing Adenomas. The Journal of Clinical Endocrinology & Metabolism 2018;103:3737-47. [DOI: 10.1210/jc.2018-00746] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
30 Chang CH, Hu YH, Tsai YC, Wu CH, Wang SM, Lin LY, Lin YH, Satoh F, Wu KD, Wu VC. Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy. Oncotarget 2017;8:29984-95. [PMID: 28415786 DOI: 10.18632/oncotarget.16269] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
31 Wu C, Wu V, Yang Y, Lin Y, Yang S, Lin P, Chang C, Tsai Y, Wang S, Wu V, Wu C, Hu Y, Kiaw L, Chang C, Chang Y, Tsai Y, Yu C, Lin Y, Chan C, Lin J, Wang W, Ho Y, Chang H, Lin L, Hu F, Chang C, Liu K, Wang S, Huang K, Jeff Chueh S, Liao S, Lu C, Yen R, Wu K; TAIPAI group. Plasma Aldosterone After Seated Saline Infusion Test Outperforms Captopril Test at Predicting Clinical Outcomes After Adrenalectomy for Primary Aldosteronism. American Journal of Hypertension 2019;32:1066-74. [DOI: 10.1093/ajh/hpz098] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
32 Inoue K, Yamazaki Y, Kitamoto T, Hirose R, Saito J, Omura M, Sasano H, Nishikawa T. Aldosterone Suppression by Dexamethasone in Patients With KCNJ5-Mutated Aldosterone-Producing Adenoma. J Clin Endocrinol Metab 2018;103:3477-85. [PMID: 30020487 DOI: 10.1210/jc.2018-00738] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
33 Seidel E, Scholl UI. Intracellular Molecular Differences in Aldosterone- Compared to Cortisol-Secreting Adrenal Cortical Adenomas. Front Endocrinol (Lausanne) 2016;7:75. [PMID: 27445978 DOI: 10.3389/fendo.2016.00075] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
34 Tan GC, Negro G, Pinggera A, Tizen Laim NMS, Mohamed Rose I, Ceral J, Ryska A, Chin LK, Kamaruddin NA, Mohd Mokhtar N, A. Jamal AR, Sukor N, Solar M, Striessnig J, Brown MJ, Azizan EA. Aldosterone-Producing Adenomas: Histopathology–Genotype Correlation and Identification of a Novel CACNA1D Mutation. Hypertension 2017;70:129-36. [DOI: 10.1161/hypertensionaha.117.09057] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 5.2] [Reference Citation Analysis]
35 Rege J, Turcu AF, Rainey WE. Primary aldosteronism diagnostics: KCNJ5 mutations and hybrid steroid synthesis in aldosterone-producing adenomas. Gland Surg 2020;9:3-13. [PMID: 32206594 DOI: 10.21037/gs.2019.10.22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Morimoto R, Omata K, Ito S, Satoh F. Progress in the Management of Primary Aldosteronism. Am J Hypertens 2018;31:522-31. [PMID: 29534182 DOI: 10.1093/ajh/hpy018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
37 Peng KY, Liao HW, Chan CK, Lin WC, Yang SY, Tsai YC, Huang KH, Lin YH, Chueh JS, Wu VC. Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success. Hypertension 2020;76:1537-44. [PMID: 32921192 DOI: 10.1161/HYPERTENSIONAHA.120.15328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
38 Kamilaris CDC, Hannah-Shmouni F, Stratakis CA. Adrenocortical tumorigenesis: Lessons from genetics. Best Pract Res Clin Endocrinol Metab 2020;34:101428. [PMID: 32507359 DOI: 10.1016/j.beem.2020.101428] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
39 Chang CH, Yang SS, Tsai YC, Kuo SW, Cherng SC, Lu CC, Yen RF, Wu VC, Hu YH. Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications. Ci Ji Yi Xue Za Zhi 2018;30:169-75. [PMID: 30069126 DOI: 10.4103/tcmj.tcmj_106_17] [Reference Citation Analysis]
40 Chang YY, Pan CT, Chen ZW, Tsai CH, Peng SY, Chang CC, Lee BC, Liao CW, Peng KY, Chiu YW, Chou CH, Wu VC, Liu LD, Hung CS, Lin YH. KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated with a Greater Recovery of Arterial Stiffness. Cancers (Basel) 2021;13:4313. [PMID: 34503121 DOI: 10.3390/cancers13174313] [Reference Citation Analysis]
41 Stafford N, Wilson C, Oceandy D, Neyses L, Cartwright EJ. The Plasma Membrane Calcium ATPases and Their Role as Major New Players in Human Disease. Physiol Rev 2017;97:1089-125. [PMID: 28566538 DOI: 10.1152/physrev.00028.2016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 9.2] [Reference Citation Analysis]
42 Meyer LS, Reincke M, Williams TA. Timeline of Advances in Genetics of Primary Aldosteronism. Exp Suppl 2019;111:213-43. [PMID: 31588534 DOI: 10.1007/978-3-030-25905-1_11] [Reference Citation Analysis]
43 Lin JH, Lin YF, Wang WJ, Lin YF, Chueh SJ, Wu VC, Chu TS, Wu KD; Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group. Plasma Aldosterone Concentration as a Determinant for Statin Use among Middle-Aged Hypertensive Patients for Atherosclerotic Cardiovascular Disease. J Clin Med 2018;7:E382. [PMID: 30355992 DOI: 10.3390/jcm7110382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Chan CK, Chang YY, Tsai YC, Chen ZW, Wu CY, Huang WC, Yen IW, Wu KH, Wu VC, Lin YH; TAIPAI Study Group. Taiwan mini-frontier of primary aldosteronism: Updating treatment and comorbidities detection. J Formos Med Assoc 2021:S0929-6646(21)00137-6. [PMID: 33906783 DOI: 10.1016/j.jfma.2021.03.032] [Reference Citation Analysis]
45 Kamilaris CDC, Stratakis CA, Hannah-Shmouni F. Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism. Front Endocrinol (Lausanne) 2021;12:632543. [PMID: 33776926 DOI: 10.3389/fendo.2021.632543] [Reference Citation Analysis]
46 Vaidya A, Mulatero P, Baudrand R, Adler GK. The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment. Endocr Rev 2018;39:1057-88. [PMID: 30124805 DOI: 10.1210/er.2018-00139] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 22.0] [Reference Citation Analysis]
47 Chang YY, Tsai CH, Peng SY, Chen ZW, Chang CC, Lee BC, Liao CW, Pan CT, Chen YL, Lin LC, Chang YR, Peng KY, Chou CH, Wu VC, Hung CS, Lin YH; TAIPAI Study Group. KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated With a Worse Baseline Status and Better Recovery of Left Ventricular Remodeling and Diastolic Function. Hypertension 2021;77:114-25. [PMID: 33249859 DOI: 10.1161/HYPERTENSIONAHA.120.15679] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
48 Murakami M, Yoshimoto T, Nakano Y, Tsuchiya K, Minami I, Bouchi R, Fujii Y, Nakabayashi K, Hashimoto K, Hata KI, Kihara K, Ogawa Y. Expression of inflammation-related genes in aldosterone-producing adenomas with KCNJ5 mutation. Biochem Biophys Res Commun 2016;476:614-9. [PMID: 27282482 DOI: 10.1016/j.bbrc.2016.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
49 Wu VC, Wang SM, Chang CH, Hu YH, Lin LY, Lin YH, Chueh SC, Chen L, Wu KD. Long term outcome of Aldosteronism after target treatments. Sci Rep 2016;6:32103. [PMID: 27586402 DOI: 10.1038/srep32103] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 10.0] [Reference Citation Analysis]
50 Seidel E, Schewe J, Scholl UI. Genetic causes of primary aldosteronism. Exp Mol Med 2019;51:1-12. [PMID: 31695023 DOI: 10.1038/s12276-019-0337-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
51 Kitamoto T, Omura M, Suematsu S, Saito J, Nishikawa T. KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma. J Hypertens 2018;36:619-27. [PMID: 29016532 DOI: 10.1097/HJH.0000000000001578] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
52 Lee MJ, Sun CY, Lu CC, Chang YS, Pan HC, Lin YH, Wu VC, Chueh JS. Urinary sodium potassium ratio is associated with clinical success after adrenalectomy in patients with unilateral primary aldosteronism. Ther Adv Chronic Dis 2021;12:2040622321990274. [PMID: 33633824 DOI: 10.1177/2040622321990274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Warachit W, Atikankul T, Houngngam N, Sunthornyothin S. Prevalence of Somatic KCNJ5 Mutations in Thai Patients With Aldosterone-Producing Adrenal Adenomas. J Endocr Soc 2018;2:1137-46. [PMID: 30283826 DOI: 10.1210/js.2018-00097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
54 Scholl UI, Healy JM, Thiel A, Fonseca AL, Brown TC, Kunstman JW, Horne MJ, Dietrich D, Riemer J, Kücükköylü S, Reimer EN, Reis AC, Goh G, Kristiansen G, Mahajan A, Korah R, Lifton RP, Prasad ML, Carling T. Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype. Clin Endocrinol (Oxf) 2015;83:779-89. [PMID: 26252618 DOI: 10.1111/cen.12873] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 11.0] [Reference Citation Analysis]
55 Biondo ED, Spontarelli K, Ababioh G, Méndez L, Artigas P. Diseases caused by mutations in the Na+/K+ pump α1 gene ATP1A1. Am J Physiol Cell Physiol 2021;321:C394-408. [PMID: 34232746 DOI: 10.1152/ajpcell.00059.2021] [Reference Citation Analysis]
56 Chan C, Kim J, Chueh E, Chang C, Lin Y, Lai T, Huang K, Lin Y, Wu V. Aldosterone level after saline infusion test could predict clinical outcome in primary aldosteronism after adrenalectomy. Surgery 2019;166:362-8. [DOI: 10.1016/j.surg.2019.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
57 Chan CK, Yang WS, Lin YH, Huang KH, Lu CC, Hu YH, Wu VC, Chueh JS, Chu TS, Chen YM. Arterial Stiffness Is Associated with Clinical Outcome and Cardiorenal Injury in Lateralized Primary Aldosteronism. J Clin Endocrinol Metab 2020;105:dgaa566. [PMID: 32835357 DOI: 10.1210/clinem/dgaa566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
58 Liao HW, Wang SM, Chan CK, Lin YH, Lin PC, Ho CH, Liu YC, Chueh JS, Wu VC. Transtubular potassium gradient predicts kidney function impairment after adrenalectomy in primary aldosteronism. Ther Adv Chronic Dis 2020;11:2040622320944792. [PMID: 32922714 DOI: 10.1177/2040622320944792] [Reference Citation Analysis]
59 Liao HW, Peng KY, Wu VC, Lin YH, Lin SL, Lin WC, Chueh JS, On Behalf Of Taipai Study Group. Characteristics of a Novel ATP2B3 K416_F418delinsN Mutation in a Classical Aldosterone-Producing Adenoma. Cancers (Basel) 2021;13:4729. [PMID: 34572956 DOI: 10.3390/cancers13184729] [Reference Citation Analysis]